Share
 
Title
Code
Session Type
Format
ROOM/CHANNEL
Date Time
Moderator
Organizer

To successfully address HIV and viral hepatitis where injecting drug use occurs, countries should prioritize implementing needle and syringe programmes NSPs and evidence-based drug dependence treatment specifically OST), HIV testing and counselling and access to antiretroviral therapy. Needle and syringe programmes (NSP) provide access to sterile injecting equipment to people who inject drugs to prevent the transmission of HIV and hepatitis B and C through shared injection equipment. While community-based NSP have been implemented in 82 countries, only 10 countries around the world report having NSP in prisons. The purpose of this session to describe and share with audience the experience of Canada in Starting and managing needle and syringe programmes in prisons and other closed settings

08:00
5 min
Opening remarks
Mark STOOVE, Burnet Institute, Australia
08:05
15 min
Prison-based Needle Exchange Programs and an Overdose Prevention Service: Perspectives of Inmates and Staff in Canadian Federal Institutions and Resultant Health Outcomes.
Lynne Elizabeth LEONARD, University of Ottawa, Canada
08:20
15 min
Impact of PNSP on national HIV/HCV prevalence in Eastern Europe and Central Asia
Ehab SALAH, United Nations Office on Drugs and Crime, Austria
08:35
5 min
Harm reduction in German prisons
Dirk SCHAEFFER, German AIDS Organisation (Deutsche AIDS Hilfe), Germany
08:40
18 min
Discussion
Lynne Elizabeth LEONARD, University of Ottawa, Canada
Mark STOOVE, Burnet Institute, Australia
Ehab SALAH, United Nations Office on Drugs and Crime, Austria
Dirk SCHAEFFER, German AIDS Organisation (Deutsche AIDS Hilfe), Germany
Fariba SOLTANI, United Nations Office on Drugs and Crime, Austria
08:58
2 min
Closing remarks
Fariba SOLTANI, United Nations Office on Drugs and Crime, Austria